✦ LIBER ✦

Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham–Stout syndrome

✍ Scribed by Gabriele Lehmann; Alexander Pfeil; Joachim Böttcher; Werner A. Kaiser; Jürgen Füller; Gert Hein; Gunter Wolf

Publisher: Springer
Year: 2008
Tongue: English
Weight: 572 KB
Volume: 129
Category: Article
ISSN: 1434-3916
DOI: 10.1007/s00402-008-0742-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-traumatic fracture of the femoral sh

Non-traumatic fracture of the femoral shaft in a patient taking long-term bisphosphonate therapy

✍ Joong Kyong Ahn; Jaejoon Lee; Hoon-Suk Cha; Eun-Mi Koh 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 180 KB

COBRA combination therapy in patients wi

COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

✍ Robert B. M. Landewé; Maarten Boers; Arco C. Verhoeven; Rene Westhovens; Mart A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Objective The Combinatietherapie Bij Reumatoide Artritis (COBRA) trial demonstrated that step‐down combination therapy with prednisolone, methotrexate, and sulfasalazine (SSZ) was superior to SSZ monotherapy for suppressing disease activity and radiologic progression of rheumatoid a

Unusual case of antiphospholipid antibod

Unusual case of antiphospholipid antibody syndrome presenting with extensive cutaneous infarcts in a patient on long-term procainamide therapy

✍ Basil F. El-Rayes; Mark Edelstein 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

The risks and benefits of long-term use

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up

✍ Martin H. Steinberg; William F. McCarthy; Oswaldo Castro; Samir K. Ballas; F. Da 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 2 views

Gangrene of the toes in a patient with c

Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy

✍ E. Leo; A. Krämer; A. Hochhaus; F. Krasniqi; R. Hehlmann; A. Ho 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 51 KB

Long-term treatment of refractory thromb

Long-term treatment of refractory thrombocytopenia in a patient with wiskott-aldrich syndrome with vincristine, immunoglobulin, and methylprednisolone

✍ Young, Guy; Angiolillo, Anne L. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

We report a child with Wiskott-Aldrich syndrome with severe, refractory, symptomatic thrombocytopenia who achieved an excellent response to combination therapy with vincristine 1.5 mg/m 2 × 1 day, intravenous immunoglobulin 1 g/kg × 3 days, and methylprednisolone 25 mg/kg × 3 days (VIM) for 7 years